Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophage activation syndrome in Still’s disease: analysis of clinical characteristics and survival in paediatric and adult patients
Piero Ruscitti, Carmela Rago, Luciana Breda, et al.
Clinical Rheumatology (2017) Vol. 36, Iss. 12, pp. 2839-2845
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

A comprehensive review on adult onset Still's disease
Roberto Giacomelli, Piero Ruscitti, Yehuda Shoenfeld
Journal of Autoimmunity (2018) Vol. 93, pp. 24-36
Closed Access | Times Cited: 345
Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies
Petros Efthimiou, Apostolos Kontzias, Peter Hur, et al.
Seminars in Arthritis and Rheumatism (2021) Vol. 51, Iss. 4, pp. 858-874
Open Access | Times Cited: 139
Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 30
EULAR/PReS recommendations for the diagnosis and management of Still’s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still’s disease
Bruno Fautrel, Stéphane Mitrovic, Arianna De Matteis, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 12, pp. 1614-1627
Closed Access | Times Cited: 26
Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort
Piero Ruscitti, Daniela Iacono, Francesco Ciccia, et al.
The Journal of Rheumatology (2018) Vol. 45, Iss. 6, pp. 864-872
Open Access | Times Cited: 78
Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still’s disease: A meta-analysis
Yubo Ma, Meng–Huang Wu, Xu Zhang, et al.
Modern Rheumatology (2017) Vol. 28, Iss. 5, pp. 849-857
Open Access | Times Cited: 66
Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still’s disease
Ji-Won Kim, Ju‐Yang Jung, Chang‐Hee Suh, et al.
Clinical Rheumatology (2020) Vol. 40, Iss. 2, pp. 661-668
Closed Access | Times Cited: 55
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations
Piero Ruscitti, Paola Di Benedetto, Onorina Berardicurti, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 52
The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature
Roberto Giacomelli, Jurgen Sota, Piero Ruscitti, et al.
Clinical and Experimental Rheumatology (2021) Vol. 39, Iss. 1, pp. 187-195
Open Access | Times Cited: 47
Systemic juvenile idiopathic arthritis and adult-onset Still’s disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still’s disease
Arianna De Matteis, Sara Bindoli, Fabrizio De Benedetti, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 12, pp. 1748-1761
Closed Access | Times Cited: 8
Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients
Piero Ruscitti, Onorina Berardicurti, Daniela Iacono, et al.
Arthritis Research & Therapy (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 44
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still’s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort
Paola Di Benedetto, Paola Cipriani, Daniela Iacono, et al.
PLoS ONE (2020) Vol. 15, Iss. 7, pp. e0235326-e0235326
Open Access | Times Cited: 43
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease
Piero Ruscitti, Valentina Natoli, Alessandro Consolaro, et al.
Lara D. Veeken (2022) Vol. 61, Iss. 10, pp. 4124-4129
Open Access | Times Cited: 27
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome
Piero Ruscitti, Paola Cipriani, Paola Di Benedetto, et al.
Clinical & Experimental Immunology (2017) Vol. 191, Iss. 2, pp. 220-228
Open Access | Times Cited: 44
Pathogenesis of adult onset still’s disease: current understanding and new insights
Piero Ruscitti, Roberto Giacomelli
Expert Review of Clinical Immunology (2018) Vol. 14, Iss. 11, pp. 965-976
Closed Access | Times Cited: 44
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study
Piero Ruscitti, Paola Cipriani, Vasiliki Liakouli, et al.
Medicine (2019) Vol. 98, Iss. 15, pp. e15123-e15123
Open Access | Times Cited: 39
Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still’s disease: case report and review of the literature
Jihad Ben Gabr, Eric Liu, Sundus Mian, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 14, pp. 887-887
Open Access | Times Cited: 38
Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still’s Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults
Toshihiko Shiga, Yuji Nozaki, Daisuke Tomita, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31
Incidence and survival of haemophagocytic lymphohistiocytosis: A population‐based cohort study from England
Joe West, Tim Card, Mark Bishton, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 4, pp. 493-504
Open Access | Times Cited: 28
The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry
Piero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 7, pp. 1141-1152
Closed Access | Times Cited: 4
Molecular and Cellular Mechanisms of Arthritis in Children and Adults: New Perspectives on Applied Photobiomodulation
Laura Marinela Ailioaie, Gerhard Litscher
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6565-6565
Open Access | Times Cited: 29
Development and Implementation of the AIDA International Registry for Patients With Still's Disease
Antonio Vitale, Francesca Della Casa, Giuseppe Lopalco, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 19
Fever of Unknown Origin: Clinical Significance of the Etiology and Common Inflammatory Parameters
Nana Xie, Wencong Zhang, Fangbing Tian, et al.
Diagnostic Microbiology and Infectious Disease (2025) Vol. 112, Iss. 3, pp. 116801-116801
Closed Access
Macrophage Activation Syndrome in Adult-Onset Still’s Disease: Challenges in Early Detection and Management
Anil Regmi, Claire Hale, Na Lin, et al.
Cureus (2025)
Open Access
Neutrophilic Urticarial Dermatosis: A Window into Systemic Inflammation and Autoimmune Disorders
Xiaoxuan Cai, Yadan Zheng, Changyi Yang, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top